Correlation Between Nouveau Life and Dakshidin

Can any of the company-specific risk be diversified away by investing in both Nouveau Life and Dakshidin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nouveau Life and Dakshidin into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nouveau Life Pharmaceuticals and Dakshidin Corporation, you can compare the effects of market volatilities on Nouveau Life and Dakshidin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nouveau Life with a short position of Dakshidin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nouveau Life and Dakshidin.

Diversification Opportunities for Nouveau Life and Dakshidin

0.28

Correlation Coefficient

Nouveau Life  Dakshidin

Modest diversification

The 3 months correlation between Nouveau and Dakshidin is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Nouveau Life Pharmaceuticals and Dakshidin Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dakshidin and Nouveau Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nouveau Life Pharmaceuticals are associated (or correlated) with Dakshidin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dakshidin has no effect on the direction of Nouveau Life i.e., Nouveau Life and Dakshidin go up and down completely randomly.

Pair Corralation between Nouveau Life and Dakshidin

Given the investment horizon of 90 days Nouveau Life Pharmaceuticals is expected to generate 3.76 times more return on investment than Dakshidin. However, Nouveau Life is 3.76 times more volatile than Dakshidin Corporation. It trades about 0.15 of its potential returns per unit of risk. Dakshidin Corporation is currently generating about -0.04 per unit of risk. If you would invest  0.02  in Nouveau Life Pharmaceuticals on December 30, 2024 and sell it today you would earn a total of  0.00  from holding Nouveau Life Pharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.41%
Values	Daily Returns

Nouveau Life Pharmaceuticals  vs.  Dakshidin Corp.

Nouveau Life Pharmac

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nouveau Life Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Nouveau Life showed solid returns over the last few months and may actually be approaching a breakup point.

Dakshidin

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dakshidin Corporation has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Nouveau Life and Dakshidin

The main advantage of trading using opposite Nouveau Life and Dakshidin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nouveau Life position performs unexpectedly, Dakshidin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dakshidin will offset losses from the drop in Dakshidin's long position.

The idea behind Nouveau Life Pharmaceuticals and Dakshidin Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.